Literature DB >> 25746674

A novel PAX6 deletion in a Chinese family with congenital aniridia.

Qiong Liu1, Wencui Wan2, Yaning Liu1, Yuying Liu2, Zhengmao Hu1, Hui Guo1, Kun Xia3, Xueming Jin4.   

Abstract

Aniridia is a rare, congenital ocular disorder with the characteristics of incomplete formation of the iris caused by the mutations of the paired box gene-6 (PAX6). To investigate the clinical characterization and the underlying genetic defect in a Chinese family with autosomal dominant aniridia, we recruited the family members who underwent comprehensive ophthalmic examination. A novel heterozygous PAX6 deletion mutation c.796 del G (p.A266 fs) (GenBank ID: KP255960) in exon 10 was exclusively observed in all affected individuals but not in any of the unaffected family members or unrelated controls. The PAX6 mRNA level was about 50% lower in patients with aniridia than in unaffected family members, indicating that this mutation caused nonsense-mediated mRNA decay. In conclusion, we identified a novel deletion mutation in the PAX6 gene resulting in an abnormal PAX6 COOH-terminal extension in the Chinese family with aniridia. Our study further expands the mutation spectrum of PAX6.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Aniridia; Frameshift mutation; PAX6

Mesh:

Substances:

Year:  2015        PMID: 25746674     DOI: 10.1016/j.gene.2015.03.001

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Novel variants in PAX6 gene caused congenital aniridia in two Chinese families.

Authors:  R Zhang; S Linpeng; X Wei; H Li; Y Huang; J Guo; Q Wu; D Liang; L Wu
Journal:  Eye (Lond)       Date:  2017-02-03       Impact factor: 3.775

2.  Targeted Exome Sequencing of Congenital Cataracts Related Genes: Broadening the Mutation Spectrum and Genotype-Phenotype Correlations in 27 Chinese Han Families.

Authors:  Yi Zhai; Jinyu Li; Wangshu Yu; Sha Zhu; Yinhui Yu; Menghan Wu; Guizhen Sun; Xiaohua Gong; Ke Yao
Journal:  Sci Rep       Date:  2017-04-27       Impact factor: 4.996

3.  Epistasis between Pax6Sey and genetic background reinforces the value of defined hybrid mouse models for therapeutic trials.

Authors:  Jack W Hickmott; Uvini Gunawardane; Kimberly Jensen; Andrea J Korecki; Elizabeth M Simpson
Journal:  Gene Ther       Date:  2018-09-26       Impact factor: 5.250

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.